Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Lorus presents data on Virulizin at AACR

April 29, 2002

Zadaxin leads to bone marrow recovery after chemotherapy

April 25, 2002

Lynx and Wilex collaborate to identify genes regulated by WX-G250

April 24, 2002

SGN-30, a chimeric anti-CD30 MAb, in the treatment of Hodgkin's disease

April 23, 2002

Patient treatment begun in phase I/IIa trial of ZYC-300

April 18, 2002

Over 95% of prostate cancer patients express target of Provenge vaccine

April 16, 2002

Phase I/II results for WX-G250 in metastatic RCC indicate clinical benefit and good tolerance

April 15, 2002

Long-term survival findings reported for Multikine in head and neck cancer

April 12, 2002

MVA-Muc1-IL-2 enters new phase II trial in prostate cancer

April 10, 2002

LifeTime acquires Beta LT

April 8, 2002

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...